A novel strategy to enhance T cell-mediated immunity to vaccine antigens

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1000703

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Globally there are about 33 million people living with HIV. The disease has already resulted in 23 million deaths and 2.5 million people are newly infected each year. Similarly, TB kills nearly 2 million people every year and infects about 1% of the worldÍs population every year. A vaccine is the best and also likely the only long-term solution for HIV/TB disease prevention. This research proposal looks at novel strategies to increase the efficacy of vaccines for diseases such as HIV/TB.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2013

Funding Scheme: Development Grants

Funding Amount: $234,592.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cellular Immunology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

T cell immunity | cytokine regulation | cytokines | human immunodeficiency virus (HIV) | infectious diseases | mucosal immunity | tuberculosis | vaccine development | vaccines | viral immunity

Related Links